Published in Am J Ophthalmol on July 30, 2008
Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography. Ophthalmology (2010) 1.93
Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials. Ophthalmology (2014) 1.45
Histologic basis of variations in retinal pigment epithelium autofluorescence in eyes with geographic atrophy. Ophthalmology (2013) 1.43
Progression of geographic atrophy and genotype in age-related macular degeneration. Ophthalmology (2010) 1.18
Association between geographic atrophy progression and reticular pseudodrusen in eyes with dry age-related macular degeneration. Invest Ophthalmol Vis Sci (2013) 1.11
Reticular macular disease is associated with multilobular geographic atrophy in age-related macular degeneration. Retina (2013) 1.00
Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial. Invest Ophthalmol Vis Sci (2010) 0.98
Changes in retinal sensitivity in geographic atrophy progression as measured by microperimetry. Invest Ophthalmol Vis Sci (2011) 0.94
Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects. Clin Ophthalmol (2015) 0.91
Selective retina therapy (SRT) in patients with geographic atrophy due to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2009) 0.88
Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degeneration. PLoS One (2015) 0.87
Ten-year follow-up of eyes treated with stereotactic fractionated external beam radiation for neovascular age-related macular degeneration. Retina (2011) 0.85
[Therapy approaches for geographic atrophy]. Ophthalmologe (2010) 0.83
Dietary folate, B vitamins, genetic susceptibility and progression to advanced nonexudative age-related macular degeneration with geographic atrophy: a prospective cohort study. Am J Clin Nutr (2016) 0.81
Fundus autofluorescence imaging in dry AMD: 2014 Jules Gonin lecture of the Retina Research Foundation. Graefes Arch Clin Exp Ophthalmol (2014) 0.79
Evaluation of Geographic Atrophy from Color Photographs and Fundus Autofluorescence Images: Age-Related Eye Disease Study 2 Report Number 11. Ophthalmology (2016) 0.78
Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents. Eye (Lond) (2016) 0.78
Geographic Atrophy and Choroidal Neovascularization in the Same Eye: A Review. Ophthalmic Res (2016) 0.77
Characteristics of incident geographic atrophy in the complications of age-related macular degeneration prevention trial. Ophthalmology (2013) 0.76
VISUAL FUNCTION MEASURES IN EARLY AND INTERMEDIATE AGE-RELATED MACULAR DEGENERATION. Retina (2016) 0.75
GEOGRAPHIC ATROPHY: Semantic Considerations and Literature Review. Retina (2016) 0.75
Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials. Ophthalmology (2016) 0.75
Effect of topical isopropyl unoprostone on macular atrophy progression in eyes with exudative age-related macular degeneration. Medicine (Baltimore) (2017) 0.75
THE PATHOPHYSIOLOGY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION AND THE COMPLEMENT PATHWAY AS A THERAPEUTIC TARGET. Retina (2016) 0.75
[Clinical characteristics, progression and risk factors of geographic atrophy]. Ophthalmologe (2010) 0.75
Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol (2004) 13.78
Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology (1992) 10.88
The Wisconsin age-related maculopathy grading system. Ophthalmology (1991) 7.62
The Beaver Dam Eye Study: visual acuity. Ophthalmology (1991) 6.87
The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology (1997) 6.47
Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06
Evolution of geographic atrophy of the retinal pigment epithelium. Eye (Lond) (1988) 4.47
Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology (2007) 3.96
Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology (2002) 3.80
Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology (2004) 3.53
Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol (2007) 3.00
Changes in visual acuity in a population. The Beaver Dam Eye Study. Ophthalmology (1996) 2.98
Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol (2006) 2.80
Changes in visual acuity in a population over a 15-year period: the Beaver Dam Eye Study. Am J Ophthalmol (2006) 2.77
Changes in visual acuity in a population over a 10-year period : The Beaver Dam Eye Study. Ophthalmology (2001) 2.71
The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol (2003) 2.63
The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology (2003) 2.49
Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration. Ophthalmology (1999) 2.26
The validity of self-reported and surrogate-reported cataract and age-related macular degeneration in the Beaver Dam Eye Study. Am J Epidemiol (1991) 2.14
Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci (2001) 2.04
Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Arch Ophthalmol (2003) 2.04
Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial. Arch Ophthalmol (2007) 1.89
Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. Arch Ophthalmol (1995) 1.76
Blood pressure, atherosclerosis, and the incidence of age-related maculopathy: the Rotterdam Study. Invest Ophthalmol Vis Sci (2003) 1.69
The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials. Ophthalmology (2007) 1.63
Atrophic macular degeneration. Rate of spread of geographic atrophy and visual loss. Ophthalmology (1989) 1.53
Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study. Ophthalmology (2002) 1.51
Geographic atrophy of the retinal pigment epithelium. Am J Ophthalmol (1986) 1.34
14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. Ophthalmology (2005) 1.15
Modelling the natural history of geographic atrophy in patients with age-related macular degeneration. Ophthalmic Epidemiol (2005) 1.11
Seven year follow-up of age-related maculopathy in an elderly British population. Eye (Lond) (1997) 0.98
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83
Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol (2006) 4.68
The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol (2005) 4.46
Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA (2010) 4.41
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30
Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Ophthalmology (2007) 3.96
The impact of hearing loss on quality of life in older adults. Gerontologist (2003) 3.87
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology (2002) 3.80
Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch Ophthalmol (2004) 3.78
Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology (2004) 3.53
Revised formulas for summarizing retinal vessel diameters. Curr Eye Res (2003) 3.47
Prevalence of olfactory impairment in older adults. JAMA (2002) 3.46
Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies. Lancet (2008) 3.42
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology (2008) 3.37
The 5-year incidence and progression of hearing loss: the epidemiology of hearing loss study. Arch Otolaryngol Head Neck Surg (2003) 3.17
Prevalence of age-related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology (2006) 2.95
Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration. Am J Hum Genet (2003) 2.92
The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol (2006) 2.89
Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol (2011) 2.89
Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA). Invest Ophthalmol Vis Sci (2006) 2.79
Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA (2002) 2.78
Changes in visual acuity in a population over a 15-year period: the Beaver Dam Eye Study. Am J Ophthalmol (2006) 2.77
Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA (2002) 2.72
Detection of age-related macular degeneration using a nonmydriatic digital camera and a standard film fundus camera. Arch Ophthalmol (2004) 2.67
The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology (2003) 2.49
Genome-wide meta-analyses of multiancestry cohorts identify multiple new susceptibility loci for refractive error and myopia. Nat Genet (2013) 2.36
Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet (2005) 2.34
Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology (2004) 2.26
The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol (2008) 2.24
Generational differences in the prevalence of hearing impairment in older adults. Am J Epidemiol (2009) 2.18
Retinal arteriolar diameter and risk for hypertension. Ann Intern Med (2004) 2.18
Enduring effects of prenatal and infancy home visiting by nurses on children: follow-up of a randomized trial among children at age 12 years. Arch Pediatr Adolesc Med (2010) 2.18
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height. Am J Hum Genet (2010) 2.15
Prospective cohort study of retinal vessel diameters and risk of hypertension. BMJ (2004) 2.10
Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology (2007) 2.07
Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmology (2003) 2.04
The relation of retinal vessel caliber to the incidence and progression of diabetic retinopathy: XIX: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol (2004) 2.03
Retinal microvascular abnormalities and risk of lacunar stroke: Atherosclerosis Risk in Communities Study. Stroke (2010) 1.91
Are inflammatory factors related to retinal vessel caliber? The Beaver Dam Eye Study. Arch Ophthalmol (2006) 1.89
Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med (2004) 1.89
Further observations on the association between smoking and the long-term incidence and progression of age-related macular degeneration: the Beaver Dam Eye Study. Arch Ophthalmol (2008) 1.89
Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. Am J Epidemiol (2002) 1.87
The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes. Ophthalmology (2009) 1.87
Retinal vascular caliber in persons with type 2 diabetes: the Wisconsin Epidemiological Study of Diabetic Retinopathy: XX. Ophthalmology (2006) 1.83
Aortic distensibility and retinal arteriolar narrowing: the multi-ethnic study of atherosclerosis. Hypertension (2007) 1.83
EPHA2 is associated with age-related cortical cataract in mice and humans. PLoS Genet (2009) 1.82
Refractive errors, intraocular pressure, and glaucoma in a white population. Ophthalmology (2003) 1.81
Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons. JAMA (2002) 1.80
Genome-wide linkage study of retinal vessel diameters in the Beaver Dam Eye Study. Hypertension (2006) 1.80
Identification of novel genetic loci for intraocular pressure: a genomewide scan of the Beaver Dam Eye Study. Arch Ophthalmol (2007) 1.79
The prevalence of age-related macular degeneration and associated risk factors. Arch Ophthalmol (2010) 1.78
Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke (2002) 1.77
The prevalence of hearing impairment and associated risk factors: the Beaver Dam Offspring Study. Arch Otolaryngol Head Neck Surg (2011) 1.76
Frailty, morbidity and survival. Arch Gerontol Geriatr (2005) 1.75
Incidence of dry eye in an older population. Arch Ophthalmol (2004) 1.74
Statin use and the five-year incidence and progression of age-related macular degeneration. Am J Ophthalmol (2007) 1.73
Relationship between white blood cell count and incident hypertension. Am J Hypertens (2004) 1.73
The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study. Ophthalmology (2002) 1.73
Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25. Ophthalmology (2008) 1.69
Retinal vessel diameters and their associations with age and blood pressure. Invest Ophthalmol Vis Sci (2003) 1.69
Examining the relative influence of familial, genetic, and environmental covariate information in flexible risk models. Proc Natl Acad Sci U S A (2009) 1.68
Socioeconomic status and subclinical atherosclerosis in older adults. Prev Med (2010) 1.67
Relationship of retinal vascular caliber with diabetes and retinopathy: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care (2007) 1.66
Retinal vessel diameter and cardiovascular mortality: pooled data analysis from two older populations. Eur Heart J (2007) 1.65
Retinal and cerebral microvascular signs and diabetes: the age, gene/environment susceptibility-Reykjavik study. Diabetes (2008) 1.62
Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. Am J Epidemiol (2009) 1.60
Air Pollution and the microvasculature: a cross-sectional assessment of in vivo retinal images in the population-based multi-ethnic study of atherosclerosis (MESA). PLoS Med (2010) 1.59
Age-related eye disease, visual impairment, and survival: the Beaver Dam Eye Study. Arch Ophthalmol (2006) 1.58
Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo. PLoS Genet (2010) 1.57
Is diabetic retinopathy related to subclinical cardiovascular disease? Ophthalmology (2010) 1.56
Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study. Invest Ophthalmol Vis Sci (2004) 1.56
Education, occupation, noise exposure history and the 10-yr cumulative incidence of hearing impairment in older adults. Hear Res (2009) 1.55
Meta-analysis: retinal vessel caliber and risk for coronary heart disease. Ann Intern Med (2009) 1.54
Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int (2011) 1.53
Prevalence of age-related macular degeneration in old persons: Age, Gene/environment Susceptibility Reykjavik Study. Ophthalmology (2010) 1.52
The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States. Arch Ophthalmol (2004) 1.52
The risk of posterior subcapsular cataracts in granulocyte donors. Transfusion (2005) 1.52
The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. Arch Ophthalmol (2002) 1.51
The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam Eye Study. Trans Am Ophthalmol Soc (2006) 1.51
Long-term incidence of dry eye in an older population. Optom Vis Sci (2008) 1.51
The epidemiology of retinal reticular drusen. Am J Ophthalmol (2007) 1.50